PharmaVoice

FEBRUARY 20, 2024

While buzz builds around “off the shelf” CAR-T cell therapies, Kite is staying competitive with a shorter manufacturing turnaround and a focus on broadening applications.

Competition 173

Competition Manufacturing 173

European Pharmaceutical Review

AUGUST 22, 2023

According to UK Research and Innovation ( UKRI ), £13 million is set to fund medicine manufacturing in the UK, through a focus on innovation in intracellular drug delivery, digitalisation and automation and nucleic acid medicines. Seventeen new projects from the Innovate UK Transforming Medicine Manufacturing programme will benefit.

Medicine 98

Medicine Manufacturing Biopharma Competition 98

European Pharmaceutical Review

NOVEMBER 1, 2023

Washington State University researchers have developed a centrifugal bioreactor that is able to manufacture T cells, at 95 percent of the maximum growth rate — about 30 percent quicker than current technologies. I really hope having novel technologies to help with manufacturing reduces that financial barrier for these life-saving therapies.”

Manufacturing 104

Manufacturing Engineering Competition Pharmaceutical 104

European Pharmaceutical Review

FEBRUARY 2, 2023

While maintaining a healthy manufacturing industry for production of ‘high tech’ pharmaceuticals, Europe has stepped away from manufacturing essential medicines and active pharmaceutical ingredients (APIs) due to unrelenting price pressures and is now heavily reliant on the import of these critical ingredients.

Medicine 111

Medicine Manufacturing Pharmaceutical Specialization 111

Pharmaceutical Technology

SEPTEMBER 11, 2023

With many biopharma companies outsourcing for manufacturing support, how can your organisation outpace the competition?

Competition 59

Competition Pharmaceutical manufacturing Manufacturing Biopharma 59

European Pharmaceutical Review

APRIL 11, 2024

The pharmaceutical industry is becoming increasingly conscious of emissions and the importance of sustainable manufacturing. 1 Every major pharmaceutical manufacturer in the UK and Ireland is investing in making their operations and supply chains more environmentally friendly.

Manufacturing 105

Manufacturing Pharmaceutical Engineering Pharmaceutical manufacturing 105

European Pharmaceutical Review

DECEMBER 4, 2023

To address these issues, companies should adopt more advanced production strategies such as continuous flow chemistry, as they can shorten manufacturing processes, increase productivity and throughput. These insights help to drive highly efficient manufacturing processes, ensuring competitive product delivery on time and within budget.

Pharmaceutical manufacturing 105

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharmaceutical products 105

European Pharmaceutical Review

AUGUST 22, 2022

percent of biopharmaceutical companies outsource at least some of their activities, which has helped make biopharmaceutical contract manufacturing a $14 billion industry. The investigators foresee a highly promising and profitable future for biopharmaceutical contract development and manufacturing organisations (CDMOs) over the next decade.

Biopharma 98

Biopharma Manufacturing Marketing Competition 98

Pharmaceutical Technology

MARCH 10, 2023

On 10 March, the National Health Service Blood and Transplant (NHSBT) opened a new Clinical Biotechnology Centre (CBC) with the aim of improving the UK’s ability to develop and manufacture cell and gene therapies. This is important due to the UK’s currently limited short-scale manufacturing capacity.

Manufacturing 105

Manufacturing Medicine Distribution Patients 105

European Pharmaceutical Review

DECEMBER 6, 2023

In the interview, conducted at CPHI Barcelona, Krishna Venkatesh, Global Head, Sterile Manufacturing Operations at Dr Reddy’s Laboratories explores industry’s growing focus on achieving end-to-end connectivity, as well as the potential of automation and track and trace solutions. KV : We have seen two specific elements.

Manufacturing 98

Manufacturing Engineering Pharmaceutical manufacturing Pharmaceutical 98

Fierce Pharma

JULY 11, 2023

That’s good news for Bristol Myers Squibb, which has secured a few more competition-free months for its aging leukemia blockbuster Sprycel. . | With Xspray Pharma and Eversana’s cancer med hitting a regulatory setback, a launch in the second half of 2023 now looks unlikely.

Manufacturing 124

Manufacturing Competition Pharma FDA 124

European Pharmaceutical Review

FEBRUARY 13, 2025

Based on the new cost estimates, pharmaceutical manufacturers in Finland alone will be required to fund 280816 million of these expenses, The directive , enforced on 1 January 2025, imposes an extended manufacturer responsibility on the removal of micro-pollutants from wastewaters.

Medicine 59

Medicine Pharmaceutical manufacturing Manufacturing Competition 59

European Pharmaceutical Review

NOVEMBER 30, 2023

o find out about the current trends in cell and gene therapy manufacturing, EPR spoke to Cell and Gene Therapy Catapult (CGT Catapult)’s Chief Manufacturing Officer, Stephen Ward, and Chief Business Officer, Jeanette Evans. Licensing of the manufacturing suites is expected in early 2024. So now we have a really nice blend.”

Manufacturing 97

Manufacturing Recruitment Medicine Biopharma 97

World of DTC Marketing

APRIL 12, 2021

Pharmaceutical manufacturers and distributors work together in a robust system to deliver high-quality products, but drug manufacturing and distribution have become increasingly complex in recent years. Outsourcing, which has become mainstream in pharma, has also led to competition that doesn’t always benefit patients.

Food and Drug Administration 187

Food and Drug Administration Prescription Pharma Manufacturing 187

Fierce Pharma

JANUARY 11, 2024

. | Pfizer mused on ADC opportunities in China, while Takeda's R&D head revealed details behind the company's competitive TYK2 deal with Nimbus at this year's J.P. Astellas received a manufacturing-related rejection for its gastric cancer candidate. Morgan Healthcare Conference. And more.

Competition 130

Competition Pharma Manufacturing Healthcare 130

European Pharmaceutical Review

APRIL 11, 2024

Expirations of biologic patents has enabled manufacturers to enter the market and offer lower-cost alternatives of these drugs, according to the report. This has resulted in “increased competition and price pressure, driving the growth of the biosimilar market”. million by 2032, at 17.6 percent CAGR between 2023 and 2032.

Marketing 105

Marketing Competition Manufacturing Medicine 105

European Pharmaceutical Review

JULY 29, 2024

From automation and Artificial Intelligence (AI) to Blockchain and advanced analytics, these technologies offer unprecedented opportunities to enhance data integrity throughout the manufacturing lifecycle. The importance of data integrity in Biopharma Data integrity is critical in Biopharma and a source of strong competitive advantage.

Biopharma 83

Biopharma Manufacturing Ethics Competition 83

European Pharmaceutical Review

OCTOBER 31, 2024

It pledges to benefit key industry sectors across life sciences including R&D, innovation, manufacturing and medicine. Over the last five years Made Smarter has transformed countless SME manufacturers,” stated Donna Edwards, Director of Made Smarter’s North West adoption programme.

Manufacturing 52

Manufacturing Medical science Medicine Engineering 52

European Pharmaceutical Review

FEBRUARY 17, 2025

The Association of the British Pharmaceutical Industry (ABPI) has welcomed the proposed changes, highlighting their potential to support talent development in areas such as advanced manufacturing, digital skills, and emerging biotechnologies. billion in 2017/18 to 2.5 billion in 2023/24.

Training 59

Training Pharmaceutical Government Manufacturing 59

Pharmaceutical Technology

SEPTEMBER 26, 2023

To optimise autoinjector combination product development, it is crucial for pharma and biotech to partner with device companies that have in-house control over the whole device manufacturing process.

Manufacturing 52

Manufacturing Competition Pharma 52

World of DTC Marketing

OCTOBER 5, 2021

High drug prices preferentially benefit the largest drug manufacturers, which spend only about 10 to 20 percent of their revenue on research and development — far less than they spend on marketing, administration, and stock buybacks and dividends. With that late-stage investment comes control of the lucrative patents on these products.)

Pharma 241

Pharma Insurance Sales Government 241

Pharmaceutical Technology

NOVEMBER 22, 2022

Despite China producing a significant proportion of the world’s API supply (mostly small molecule), it manufactures relatively few biosimilar and innovator drugs and no cell and gene therapies for the western markets of Europe and the US despite investments and an increasing number of startups to improve innovative manufacture.

Manufacturing 64

Manufacturing Pharma Government FDA 64

Pharmaceutical Commerce

MARCH 10, 2025

This link in the pharma supply chain is undergoing a major transformation propelled by technological advancements, regulatory changes, and evolving market dynamics, requiring industry leaders to adopt innovative strategies in order to remain competitive.

Pharmaceutical manufacturing 59

Pharmaceutical manufacturing Manufacturing Pharmaceutical Competition 59

World of DTC Marketing

FEBRUARY 21, 2022

Pfizer and Merck have chosen to designate a select few generic manufacturers to produce cheaper versions of their drugs through the Medicines Patent Pool (MPP). For less wealthy nations, competition isn’t even a possibility. Reportedly, the cost of production for molnupiravir stands at about $17.74.

Pharma 218

Pharma Competition Manufacturing Medicine 218

European Pharmaceutical Review

JULY 25, 2023

Advancements in manufacturing technology, plus availability of cost-effective treatment options are also influencing the sector. This can restrict a manufacturer’s capacity to make income. Other molecule types Small molecule API manufacturers are in fierce competition with medicines such as biologics, the report stated.

Marketing 97

Marketing Manufacturing Competition Pharmaceutical 97

KBK Communications

SEPTEMBER 13, 2021

As a healthcare manufacturer you are responsible for making sure the products you sell are of high quality and that the people who buy them know what to do with them. It is also important to understand how digital strategies can help your company grow, improve your customer service, and maintain a competitive edge in today's market.

Manufacturing 52

Manufacturing Healthcare Healthcare Competition 52

PharmaTech

AUGUST 30, 2023

In pursuit of increased competitiveness and bottom-line impact, pharmaceutical manufacturers face increasing pressure to fast-track technological innovation while maintaining regulatory compliance. technology initiatives.

Manufacturing 52

Manufacturing Pharmaceutical manufacturing Competition Pharma 52

Spotio

APRIL 30, 2024

Sales reps in the manufacturing industry face unique challenges. Competition is fierce, buyers often come to the table with preconceived notions—notions that must be adjusted to make sales—and prices continue to plummet in an attempt to win business. A strong manufacturing sales training program can help. The result?

Training 52

Training Manufacturing Sales Prospecting 52

European Pharmaceutical Review

JUNE 14, 2023

To be a superpower globally, the UK life sciences sector must not only discover and develop medicines of the future domestically, but also manufacture a significant share in the country too, according to a new report from the Medicines Manufacturing Industry Partnership (MMIP). It provides almost 45 percent of the £36.9

Medicine 52

Medicine Manufacturing Government Competition 52

PM360

SEPTEMBER 21, 2023

They do not have biosimilar or generic competition available in the market. Over the next few weeks, manufacturers will submit a range of clinical, marketing, sales, pricing, and patient data, and then meet with CMS to discuss submissions later this fall. They do not qualify for any exemption (e.g.,

Manufacturing 111

Manufacturing Marketing Competition Physicians 111

PharmaTech

NOVEMBER 14, 2022

The new facility will allow ReiThera to consolidate its competitive position as a leading CDMO specialized in viral vector production.

Specialization 74

Specialization Manufacturing Competition Leads 74

European Pharmaceutical Review

MAY 3, 2023

Influencing factors identified in the report include higher competition, competitive pricing and inflation rate, technological advancements and evolving regulatory guidelines. Enhanced interconnectivity of equipment and technologies has also put demand on manufacturing operations. These factors have led to industry 4.0

Marketing 105

Marketing Manufacturing Biopharma Competition 105

European Pharmaceutical Review

NOVEMBER 3, 2022

Results from CPhI’s 2022 Pharma Index survey , announced at this year’s CPhI Frankfurt, showed pharma confidence in growth , innovation and manufacturing quality has reached record highs, promising positive prospects for the industry in 2023 and beyond. Competitiveness. Germany (in second place) and the UK achieved double-digit growth.

Pharma 103

Pharma Manufacturing Competition Pharmaceutical products 103

PM360

JULY 26, 2023

To prepare for the second order effects of the IRA, one important step that we recommend for manufacturers is to clearly articulate and outline the remaining uncertainties regarding how the IRA will be implemented by CMS and identify scenarios most likely to impact their products. Acceptance and Consideration of Manufacturer Evidence.

Manufacturing 98

Manufacturing Pharma Competition Distribution 98

PM360

NOVEMBER 27, 2023

In this article, we investigate strategies that manufacturers could consider to optimize pricing and access opportunities for their combinations in today’s environment. This is the second article in a three-part series examining the commercial dynamics surrounding combination therapy in oncology across the U.S. and Europe.

Manufacturing 111

Manufacturing Marketing Competition Patients 111

Legacy MEDSearch

FEBRUARY 26, 2025

tariffstargeting imports from key manufacturing hubs like China, Mexico, and Canadais set to introduce new challenges that will reshape the landscape of medical device sales and manufacturing in 2025. based manufacturers relying on imported parts. A core objective of these tariffs is to bring more manufacturing back to the U.S.,

Manufacturing 52

Manufacturing Medical Sales Healthcare Provider 52

European Pharmaceutical Review

JUNE 28, 2024

The combination of both technologies is a challenge in the development of therapeutic products but brings competitive advantages that we will address in this article. The post Combining biofermentation and chemical synthesis to manufacture complex molecules in pharmaceutical applications appeared first on European Pharmaceutical Review.

Manufacturing 52

Manufacturing Pharmaceutical Competition 52